What smart money is saying about Denali Therapeutics
DNLI
No fund has written a full thesis on Denali Therapeutics in our archive, but 1 fund letter reports a position in it — most recently ACATIS Investment Report in July 2026.
1
Reported positions
0
Bought
0
Sold
1
Letter
Position history
Every position in Denali Therapeutics on record in the archive was reported in Q3 2026, across 1 fund letter, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 0 | 0 |
Fund activity · 1 position
- July 2026
“Another mostly unknown company is Denali Therapeutics, whose transport vehicle platform is nee- ded to transport enzymes or antibodies through the blood-brain barrier, so that active ingredients can reach their intended destination.”
Read the letterDenali Therapeutics
Read the letters behind these Denali Therapeutics positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger